Fig. 1

The Kaplan–Meier curves of DFS and OS for ER+/PR + and ER+/PR- breast cancer patients. The DFS (A) and OS (B) of ER+/PR + patients are significantly better than ER+/PR- patients. DFS, disease-free survival; OS, overall survival; ER, estrogen receptor; PR, progesterone receptor.